TruthArchive.ai - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0: This is Prevenar, made by Pfizer. There are several products on the market, but the concept is the same. This is one of the studies that brought this product to market. Here’s what I want to show you. You’ll notice up here, this is the number of patients in the placebo group. This where my finger is is the control group that was treated, and then this is the placebo group. Notice how many there are. What it says is you need to treat forty two thousand two hundred forty patients with the vaccine Prevenar in order to prevent forty one cases of pneumonia. And they all get the benefits of the potential side effects of the drug. Let’s look at that quickly. Section 6.2 in the package insert, lymphadenopathy cyanosis in the pediatric population, anaphylaxis, hypotonia, reduced tone in kids that get this vaccine, skin and subcutaneous disorders, vascular disorders, etcetera. In this vaccine is polysorbate 80 and aluminum as an adjuvant. Aluminum neurotoxin. Of course, there’s section 13.1. The product has not been evaluated to see if it causes cancer or interferes with reproductive health. Pretty important information to know.

Video Saved From X

reSee.it Video Transcript AI Summary
The Institute of Medicine reported in 2011 that over 150 vaccine-related injuries have not been studied, and the CDC has repeatedly been ordered to conduct these studies but has refused. The pharmaceutical companies producing vaccines, such as Merck, Sanofi, Glaxo, and Pfizer, have faced over $35 billion in penalties for misconduct. Trust in these companies is misplaced without solid scientific evidence. While vaccines should remain available for those who choose them, there is a need for rigorous scientific scrutiny. The FDA has misled the public in the past, as seen with Vioxx and opioids, raising concerns about their credibility regarding vaccine safety. The focus should be on ensuring public health, not pharmaceutical profits.

Video Saved From X

reSee.it Video Transcript AI Summary
The FDA allegedly wanted to keep Pfizer's dossier hidden for 55 years, despite knowing about the high number of deaths associated with the vaccine. No safety review board has been called, and there has been no voluntary recall. The large number of deaths is a significant signal, with most occurring within a week of vaccination. There have been reports of blood clots, heart attacks, and fatal cases of myocarditis. The consistency of these adverse events in various systems and literature supports the association. Randomized trials have shown more deaths with Pfizer than with the placebo. The vaccines are believed to be causing deaths in unfortunate individuals due to a combination of factors, including the production of lethal spike proteins.

Video Saved From X

reSee.it Video Transcript AI Summary
Pfizer presented evidence to the FDA on their trial for 6-month to 4-year-old children. Out of the 4,526 children recruited, 3,000 did not complete the trial, raising questions about the drop-off. The trial defined severe COVID as a slightly elevated heart rate or increased breaths per minute. In the vaccine group, 6 children aged 2 to 4 had severe COVID compared to only 1 in the placebo group. One child in the trial was hospitalized with fever and a seizure after being vaccinated. The trial manipulated the data by ignoring instances of COVID during specific time periods, ultimately disregarding 97% of the cases. Despite this, they concluded that the vaccine was effective based on a small number of cases.

Video Saved From X

reSee.it Video Transcript AI Summary
Vaccine recommendations typically come from the Advisory Committee of Immunization Practices (an outside consulting committee at CDC) and VRBPAC (within FDA), which recommends vaccine licensure. These committees only adopted evidence-based medicine about twelve years ago. The speaker states that during their administration, they want safety studies prior to vaccine licensure and recommendation. They claim vaccines are exempt from pre-licensing safety testing, and the COVID vaccine was the only one tested in a full placebo trial. They assert that the other 76 shots children receive between birth and 18 have not been safety tested against a placebo, meaning the risk profile is not understood. The speaker intends to remedy this.

Video Saved From X

reSee.it Video Transcript AI Summary
Four companies, Pfizer, Merck, Blackstone, and Sanofi, are responsible for producing all 72 vaccines. However, these companies have a history of criminal activity, collectively paying $35 billion in fines for falsifying science, defrauding regulators, lying to doctors, and causing the deaths of hundreds of thousands of people. For instance, Merck's product, Vioxx, was sold as a headache pill but caused heart attacks and killed around 120,500 Americans. Despite this, they only paid fines and faced no jail time. It is hard to believe that these companies, known for lying and cheating, are honest when it comes to vaccines. The vaccine industry is immune to lawsuits, making it the perfect place for these companies to avoid consequences.

Video Saved From X

reSee.it Video Transcript AI Summary
None of the 72 vaccines for children have been tested against a placebo. The speaker sued HHS in 2016 to find placebo studies for vaccines, but none were found. The safety testing for the polio vaccine was only 48 hours, while the hepatitis b vaccines were tested for 4-5 days. This means that any adverse events occurring after that time period were not considered. Without placebo testing, the risk profile of current vaccines is unknown, and it cannot be determined if vaccines cause more harm than good. The speaker questions the ethics of mandating medical products with unknown risks for children.

Video Saved From X

reSee.it Video Transcript AI Summary
We couldn't find any prelicensing safety trials for the 72 vaccines doses that are recommended for American children. Unlike other medications, vaccines were exempt from conducting safety trials that compare health outcomes between a placebo group and a vaccine group. This lack of safety trials is concerning considering the widespread use of these vaccines.

Video Saved From X

reSee.it Video Transcript AI Summary
Pfizer presented evidence to the FDA on their trial for 6-month to 4-year-old children. Out of 4,526 children, 3,000 dropped out of the trial, which is concerning. The trial defined severe COVID as a slightly raised heart rate or increased breaths per minute. In the vaccine group, 6 children aged 2 to 4 had severe COVID compared to 1 in the placebo group. One child in the trial was hospitalized after vaccination. The trial twisted the data by ignoring cases of COVID during the 3-week gap between doses and the 8-week gap after the second dose. Ultimately, they only compared a small number of cases, claiming the vaccine was effective.

Video Saved From X

reSee.it Video Transcript AI Summary
The documentary follows a growing concern: the rise of chronic illness and neurodevelopmental disorders in American children, with speakers outlining striking statistics, personal stories, and contested science around vaccines. Key facts and patterns: - A shift from decades ago to today: more than forty percent of American children now have at least one chronic health condition; estimates cited include that over fifty-four percent of kids have a chronic disease, up from twelve point eight percent in the 1980s. One speaker emphasizes that in forty years there has been “the greatest decline in human health ever recorded.” - Autism rates have surged: just a few decades ago, one in ten thousand children had autism; today, one in thirty-one. Other listed conditions include ADD/ADHD, tics/Tourette’s, narcolepsy, sleep disorders, IBS, autoimmune diseases (rheumatoid arthritis, juvenile diabetes, lupus, Crohn’s), eczema, asthma, seizures, and various neurological issues. - The central question raised: what is causing this epidemic of chronic illness in kids? The film argues that rapid increases in incidence cannot be explained by genetic change alone, which would take generations. Story and study arc: - The narrative centers on a scientist who was willing to conduct a study into vaccine safety and vaccine injury, but who faced career-risking consequences when attempting to publish or disseminate results. - The film’s narrator and investigators say they compiled hidden-camera testimonies, interviews, and raw stories from parents whose children experienced serious adverse events after vaccines (eczema, seizures, chronic GI issues, sleep apnea, language loss, autonomic and neurological symptoms, and death in some cases). Stories include a child who lost language after vaccination, triplets who regressed into severe autism after their pneumococcal shot, and families describing chronic, ongoing medical crises following vaccines. - The film frames a broader debate: vaccines are safe and effective, with extensive global use and long-standing public health endorsement. Yet it argues that the vaccine safety narrative lacks certain types of trials, particularly double-blind placebo-controlled trials for childhood vaccines. It claims that, in some cases, no such trials exist prior to licensure, and that post-licensure safety surveillance is limited or incomplete. Vaccine safety testing and regulatory claims: - The film argues that none of the 72 vaccine doses on the childhood schedule has ever been subjected to a pre-licensure double-blind placebo-controlled trial, which is presented as the gold standard of safety testing. It asserts that safety assessments and post-licensure surveillance often rely on observational data rather than randomized trials. - A critical example is the hepatitis B vaccine (Recombivax HB): the FDA-approved trial cited shows safety monitoring for only five days after each dose, with no placebo control. The film argues this is insufficient to detect autoimmune or neurodevelopmental issues that could emerge years later. - Dr. Stanley Plotkin, a leading vaccine expert, is interviewed regarding whether five days of safety monitoring captures potential autoimmune or neurological adverse events; the dialogue suggests concern about the adequacy of such safety windows and controls. - The documentary presents the notion that the absence of a placebo-controlled vaccine safety trial is used to argue safety, while retrospective studies and unblinded cohort analyses hints at potential signals that would merit more rigorous testing. Henry Ford Health System and the “vaccinated vs unvaccinated” study: - Dell and others pursue a vaccinated-versus-unvaccinated study using Henry Ford Health System data, with the aim of comparing health outcomes in vaccinated and unvaccinated children. They argue that this kind of retrospective cohort study can reveal safety signals when randomized trials are unavailable. - The study reportedly found that vaccination exposure was associated with higher risks of several chronic conditions, including asthma, atopic diseases, autoimmune diseases (e.g., rheumatoid arthritis, SLE, Guillain-Barré syndrome), and neurodevelopmental disorders. They summarize that by ten years, 57% of vaccinated children had a chronic health condition versus 17% of unvaccinated children; overall, two to four times higher risks across several categories were reported, with notable differences in neurodevelopmental outcomes. - The study reportedly found zero chronic conditions in the unvaccinated group for several categories, though the vaccinated group showed higher incidence in many categories. Autism did not reach statistical significance in this study due to small numbers. The presenters emphasize that retrospective studies have limitations (confounding, follow-up length, healthcare-seeking behavior), but argue that the signal deserves publication and replication. - The Henry Ford study reportedly faced professional and institutional barriers: a threat of defamation, failed attempts to publish, and internal resistance. The documentary showcases a dinner meeting where Dr. Marcus Zervos expresses willingness to publish but ultimately faces career risk, leading to discussions about “Galileo moments” and whether data should be released despite pushback. Industry and public health responses: - The film juxtaposes the public health consensus—vaccines save lives, the schedule is well tested, and billions of people have been studied—with dissenting voices from physicians, scientists, and parents who argue that independent, large-scale vaccinated-versus-unvaccinated analyses are necessary to truly assess safety outcomes. - It includes testimonials from doctors who faced professional pushback after expressing concerns about broader vaccine safety questions or demonstrating adverse effects in patient populations. - The documentary frames a call to replicate the retrospective study in other large health systems (e.g., Kaiser Permanente, Harvard Pilgrim, CDC’s VSD) to determine whether the Henry Ford findings hold across populations, and whether impaired health outcomes correlate with the breadth of vaccination exposure. Conclusion and call to action: - The film asserts that if the data are valid, this would constitute a sea-change in our understanding of off-target and nonspecific effects of vaccination and would necessitate reconsidering how the vaccination program is designed and implemented. - Viewers are urged to consider the evidence, demand replication, and reflect on the moral and ethical implications of vaccine safety research, balancing public health benefits with potential risks, and exploring alternate strategies to protect child health.

Video Saved From X

reSee.it Video Transcript AI Summary
We couldn't find a prelicensing safety trial for any of the 72 vaccines doses recommended for American children. Unlike other medications, vaccines were exempt from conducting safety trials that compare health outcomes between a placebo group and a vaccine group.

Video Saved From X

reSee.it Video Transcript AI Summary
In 2007 trial, the placebo contained a toxic agent, affecting the comparison between vaccine and control groups. Both groups had 3% new autoimmune conditions, but it was dismissed. The lack of questioning raises concerns about vaccine safety. Comparing the 3% to general population rates would be logical. Individuals like Julie Gerberding and Peter Marks, who have ties to big pharma, may overlook such issues. Gerberding's move from CDC director to Merck's vaccines president with a $4,000,000 bonus raises ethical questions.

Video Saved From X

reSee.it Video Transcript AI Summary
A recent study suggests that Pfizer may have excluded known deaths in the vaccine arm of its clinical trial from its data filing with the FDA in 2020. The study also found that trial subjects vaccinated with Pfizer's COVID-19 vaccine experienced a significant increase in cardiovascular deaths compared to placebo controls. This information was not disclosed by Pfizer when the FDA was evaluating the vaccine for emergency use. Additionally, researchers identified instances where Pfizer attributed potential vaccine-associated deaths to other causes, undermining vaccine safety data. The data presented to the FDA prior to the authorization of Pfizer's vaccine did not include all the deaths that occurred during the trial. The speaker raises concerns about the prioritization of profit over lives and warns against trusting Big Pharma.

Video Saved From X

reSee.it Video Transcript AI Summary
Vaccines are neither safe, effective, necessary, nor harmless, and this has been a two-hundred-year indoctrination. No vaccine has ever been proven safe because true placebos aren't used, and subjects aren't followed long enough. Safety is determined by whether the vaccine causes immediate death. Long-term effects like asthma, allergies, eczema, ADD, ADHD, neurological problems, and autoimmune diseases are not monitored. The FDA arbitrarily decided in the early 1990s that side effects appearing more than 72 hours after vaccination are unrelated.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker states they searched for years for a pre-licensing safety trial of the 72 vaccine doses effectively mandated for American children. They claim that every other medication requires a safety trial comparing health outcomes in a placebo group versus a vaccine group before FDA licensing. The speaker assumed this was also done for vaccines. They state they found out that vaccines were exempt from this requirement.

Video Saved From X

reSee.it Video Transcript AI Summary
Vaccines generate significant profits for companies. Adding just one vaccine to the infant child schedule can result in $1 billion in annual sales. The widespread COVID-19 vaccination has been highly lucrative for Pfizer, earning them $54 billion in 1.5 years. Moderna, on the other hand, made $56 billion, while Moderna made $34 billion during the same period.

Video Saved From X

reSee.it Video Transcript AI Summary
If regulatory agencies continue to rush products to market without long-term safety trials, the planet is in danger. The speaker questions what would happen if a vaccine wipes out fertility. They state that no childhood vaccines on the schedule have gone through randomized, double-blind, placebo-controlled trials. The speaker finds it alarming that Dr. Martin Macri's statement that no future vaccine will be licensed without a proper randomized controlled placebo trial is shocking to some. They accuse mainstream media of spreading misinformation by denying the absence of placebo trials, then admitting it to avoid delaying vaccine advancement. The speaker asserts the pharmaceutical industry has lied about drugs like Fenben and Vioxx and is now making vaccines. They call for accountability from the industry and the media, warning of grave danger if this does not happen. They disapprove of five-day safety trials with no placebo, especially for products given to healthy children.

Video Saved From X

reSee.it Video Transcript AI Summary
Pfizer's claim of 96% efficacy for their vaccine was questioned. The study and data were not independently verified, and Pfizer wanted to keep the data hidden for 75 years. The true effectiveness of the vaccine, based on absolute risk reduction, is less than 1%. More people died and were harmed in their trials compared to the placebo group. The vaccine's safety was questionable from the start, and it is not effective. Additionally, appropriate studies were not conducted for new variants.

Video Saved From X

reSee.it Video Transcript AI Summary
Vaccines have never undergone true placebo controlled trials, unlike other medical products. The DTP vaccine was pulled due to numerous lawsuits against drug companies, including Pfizer. In 1986, Pfizer asked the Reagan administration for immunity from liability, as they were losing more money in downstream liability than they were making in profits. Reagan suggested making vaccines safer, but Pfizer claimed they were unavoidably unsafe, a phrase now in the statute and upheld by the Supreme Court. The industry convinced the president and congress that vaccines are unavoidably unsafe, despite claims of their safety and effectiveness.

Video Saved From X

reSee.it Video Transcript AI Summary
The evidence shows that out of 344 babies in a Pfizer trial, only 3 completed it, with reasons like hospitalization and death leading to discontinuation. Less than 1% of babies finished the trial, yet it's claimed to be safe. The speaker questions the safety of these injections, citing reports of babies experiencing symptoms similar to sudden infant death syndrome.

Video Saved From X

reSee.it Video Transcript AI Summary
None of the vaccines, including the COVID vaccine, have undergone proper testing. No childhood vaccine has completed a placebo-controlled clinical trial with sufficient duration and power to confirm its safety before being administered to millions of children in America. This is not an opinion; it can be verified by anyone visiting the FDA website, where the package inserts and clinical trial documents are available for review.

Video Saved From X

reSee.it Video Transcript AI Summary
Pfizer has been forced to release previously secret documents, including FDA approval packages, due to court orders and successful FOIA requests. These documents reveal that Pfizer tested different versions of their vaccine during preclinical and clinical trials, which goes against FDA guidance. The different versions included modified RNA, unmodified RNA, self-amplifying RNA, and Spike protein alone. Surprisingly, all these versions were tested under the same investigational new drug number, despite FDA guidance stating that multiple versions should have their own individual numbers. Additionally, the toxicity of the mRNA active ingredient in the COVID-19 vaccines was never studied. This raises concerns about the regulatory process and the lack of safety testing.

Video Saved From X

reSee.it Video Transcript AI Summary
Vaccine manufacturers are uniquely protected from design defect claims, unlike manufacturers of other products like planes, cars, and drugs. This immunity was granted in 1986 through the National Childhood Vaccine Injury Act because manufacturers of the three routine childhood vaccines (MMR, Polio, and DTP) faced excessive liability and potential bankruptcy due to harm caused by their products. Instead of requiring safer products, Congress granted immunity, allowing manufacturers to continue selling vaccines regardless of potential harm. This immunity extended to all future routine childhood vaccines. Consequently, the CDC schedule has expanded from 3 injections in the first year of life in 1986 to 29 today. Pharmaceutical companies developing these vaccines know they won't be liable for injuries. Unlike typical drug trials, vaccine trials often lack placebo controls (except for the COVID-19 vaccine), have short safety review periods (days, weeks, or up to six months), and are underpowered, making it difficult to confirm product safety.

Keeping It Real

VACCINES: HONEST ANSWERS with Dr. Joel Warsh
Guests: Dr. Joel Gator Warsh
reSee.it Podcast Summary
The episode presents a wide‑ranging, data‑driven discussion about vaccines with Dr. Joel Warsh, a pediatrician and epidemiology trained clinician who authored a book aimed at balancing vaccine questions with evidence. The conversation centers on how vaccine safety is communicated, the medical community’s approach to risk, and why concerns persist among parents who notice rising autoimmune and allergic conditions, chronic illnesses, and debates over autism. Warsh stresses that vaccines are not anti‑vaccine; rather, the aim is open dialogue, rigorous safety review, and better public understanding of benefits versus harms. He notes that many questions get short shrift in public discourse, and he advocates transparency, nuance, and ongoing research rather than absolutist declarations about safety being “debunked.” The dialogue dives into core concepts of safety testing and trial design, explaining the difference between inert placebo controls and comparisons against other vaccines or existing vaccines. The guests discuss how safety signals are collected, the role of VAERS, and whether long‑term, large‑scale data can convincingly rule out rare adverse events. They debate the interpretation of data around autism, noting the scarcity of comprehensive, prospective studies across all vaccines beyond MMR and thimerosal and arguing that unanswered questions should prompt more research rather than definitive dismissals. A substantial portion is devoted to the ethical and societal questions of mandates, coercion, and herd immunity. The hosts explore how individual risk assessments intersect with the social contract to protect vulnerable populations, acknowledging that definitions of “safe” and “enough” vary widely. They discuss vaccine technologies—old versus new—and adjuvants, including aluminum and trace metals, as well as the development of mRNA vaccines, their testing history, and what “emergency use” really means. Throughout, the conversation emphasizes the importance of listening to skeptical voices, testing assumptions, and pursuing healthier, safer vaccines while avoiding vilification of dissenting views. The episode concludes with calls for more balanced media coverage and collaborative dialogue among scientists, clinicians, policymakers, and parents to restore trust and improve vaccine safety in practice.

The Joe Rogan Experience

Joe Rogan Experience #2462 - Aaron Siri
Guests: Aaron Siri
reSee.it Podcast Summary
In this episode, the discussion centers on vaccines, the regulatory framework surrounding them, the incentives within the pharmaceutical industry, and how information about vaccines has been shaped and transmitted in public discourse. The guest critiques the immunity regime that shields vaccine manufacturers from certain lawsuits, arguing that the economics of vaccines differ from other products and that this creates a distinct dynamic in safety, disclosure, and accountability. The conversation traverses the historical context of vaccine regulation, including the 1986 act that afforded manufacturers immunity and how that has influenced industry behavior, post-licensure safety monitoring, and the incentives to promote uptake. The speakers compare vaccine safety testing with that of other drugs, highlighting that most medicines undergo multi-year placebo-controlled trials, whereas vaccines for children reportedly rely on shorter safety windows, and the implications this may have for long-term safety data. They discuss how the public health establishment communicates risk and how some critics interpret official messaging as evidence of bias or suppression, touching on episodes where information about adverse events or potential harms was restricted or debated in public forums. The dialogue also addresses broader questions about how markets, litigation, and government policy shape product safety, using analogies from industry cases to illustrate why some harms are addressed through litigation while others are managed through different regulatory or compensation mechanisms. Throughout, the tone emphasizes the importance of examining primary sources, challenging assumptions, and recognizing the role of media ecosystems, platforms, and incentives in shaping what information reaches the public. The exchange keeps returning to the tension between collective public health goals and individual rights, arguing for a system that rewards transparency, accountability, and a robust, evidence-based examination of harms and benefits, even when such an analysis unsettles long-standing beliefs about vaccines and disease prevention.
View Full Interactive Feed